Saïd Afqir

1.3k total citations
62 papers, 549 citations indexed

About

Saïd Afqir is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Saïd Afqir has authored 62 papers receiving a total of 549 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 17 papers in Pulmonary and Respiratory Medicine and 16 papers in Cancer Research. Recurrent topics in Saïd Afqir's work include Ovarian cancer diagnosis and treatment (15 papers), Cancer Genomics and Diagnostics (7 papers) and Breast Cancer Treatment Studies (7 papers). Saïd Afqir is often cited by papers focused on Ovarian cancer diagnosis and treatment (15 papers), Cancer Genomics and Diagnostics (7 papers) and Breast Cancer Treatment Studies (7 papers). Saïd Afqir collaborates with scholars based in Morocco, Bangladesh and France. Saïd Afqir's co-authors include Khalid El Bairi, M. Amrani, Hassan Errihani, Nabil Ismaili, Cécile Le Page, Giuseppe Curigliano, Dario Trapani, Bruno Daniele, Mohammed Bellaoui and Naïma Abda and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and European Journal of Cancer.

In The Last Decade

Saïd Afqir

52 papers receiving 533 citations

Peers

Saïd Afqir
Hélio Humberto Angotti Carrara Brazil
J. Daniel Carreon United States
Elisa Gallerani Switzerland
Christian Monnerat Switzerland
Charles Gombé Mbalawa Republic of the Congo
Alexandre A. Jácome Brazil
Robert Klein United States
Supriya Chopra India
Timothée Olivier Switzerland
Zhibin Cheng China
Hélio Humberto Angotti Carrara Brazil
Saïd Afqir
Citations per year, relative to Saïd Afqir Saïd Afqir (= 1×) peers Hélio Humberto Angotti Carrara

Countries citing papers authored by Saïd Afqir

Since Specialization
Citations

This map shows the geographic impact of Saïd Afqir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saïd Afqir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saïd Afqir more than expected).

Fields of papers citing papers by Saïd Afqir

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saïd Afqir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saïd Afqir. The network helps show where Saïd Afqir may publish in the future.

Co-authorship network of co-authors of Saïd Afqir

This figure shows the co-authorship network connecting the top 25 collaborators of Saïd Afqir. A scholar is included among the top collaborators of Saïd Afqir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saïd Afqir. Saïd Afqir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Afqir, Saïd, et al.. (2025). Global trends in the value of simulation as a pedagogical tool in oncology: a bibliometric analysis from 2010 to 2024. Medical Education Online. 30(1). 2469779–2469779.
2.
Afqir, Saïd, et al.. (2024). Metastatic Epithelioid Hemangioendothelioma of the Bone: A Case Report and Literature Review. Cureus. 16(4). e58378–e58378. 1 indexed citations
3.
Bairi, Khalid El, et al.. (2023). Antibody–Drug Conjugates: A New Therapeutic Approach for Triple-Negative Breast Cancer. Cancer treatment and research. 188. 1–27. 4 indexed citations
4.
5.
Afqir, Saïd, et al.. (2023). Undifferentiated Sarcoma: A Rare Tumor of the Prostate. Cureus. 15(6). e41056–e41056. 1 indexed citations
6.
Afqir, Saïd, et al.. (2023). An Extranodal Site of Diffuse Large B-cell Lymphoma Presenting as Ovarian Cancer. Cureus. 15(1). e34337–e34337. 3 indexed citations
7.
Bairi, Khalid El, et al.. (2022). Exploring the prognostic impact of tumor sidedness in ovarian cancer: A population-based survival analysis of over 10,000 patients. Cancer Treatment and Research Communications. 33. 100625–100625. 2 indexed citations
8.
Bairi, Khalid El, et al.. (2022). Bevacizumab in metastatic colorectal cancer in a real-life setting – toxicity profile, survival outcomes, and impact of tumor sidedness. Współczesna Onkologia. 26(1). 32–39. 3 indexed citations
9.
Bairi, Khalid El, et al.. (2021). Neutrophil-To-Lymphocyte and Platelet-To-Lymphocyte Ratios As Predictors of Outcomes in Inflammatory Breast Cancer. Biomarkers in Medicine. 15(14). 1289–1298. 19 indexed citations
10.
Ulusakarya, Ayhan, et al.. (2021). Anti‐Programmed death‐1 therapy in advanced hepatocellular carcinoma: A real‐world experience. SHILAP Revista de lepidopterología. 9(4). 2162–2167. 2 indexed citations
11.
Bairi, Khalid El, et al.. (2021). Ovarian cancer in Morocco: Time to act is now. Gynecologic Oncology Reports. 37. 100857–100857. 1 indexed citations
12.
Bairi, Khalid El, Dario Trapani, Bouchra Ouled Amar Bencheikh, et al.. (2020). Can the microbiota predict response to systemic cancer therapy, surgical outcomes, and survival? The answer is in the gut. Expert Review of Clinical Pharmacology. 13(4). 403–421. 6 indexed citations
13.
14.
Bairi, Khalid El, Dario Trapani, Angelica Petrillo, et al.. (2020). Repurposing anticancer drugs for the management of COVID-19. European Journal of Cancer. 141. 40–61. 60 indexed citations
15.
Kinany, Khaoula El, et al.. (2019). Consumption of modern and traditional Moroccan dairy products and colorectal cancer risk: a large case control study. European Journal of Nutrition. 59(3). 953–963. 27 indexed citations
16.
Afqir, Saïd, et al.. (2017). L'oncologie médicale, nouvelle spécialité en Afrique ?. Pan African Medical Journal. 27. 36–36.
17.
Afqir, Saïd, et al.. (2014). Métastase vésicale d’un adénocarcinome gastrique en bague à chaton. Pan African Medical Journal. 19. 206–206. 1 indexed citations
18.
Ismaili, Nabil, Saïd Afqir, Rhizlane Belbaraka, et al.. (2012). Cancers urologiques : congrès de l’ECCO/ESMO 2011. La Presse Médicale. 41(12). 1181–1187. 1 indexed citations
19.
Moncharmont, Coralie, Pierre Auberdiac, Saïd Afqir, et al.. (2011). Cisplatine ou carboplatine, telle est la question. Bulletin du Cancer. 98(2). 164–175. 17 indexed citations
20.
Afqir, Saïd, Nabil Ismaili, Samir Ahid, et al.. (2009). Nasopharyngeal carcinoma in adolescents: a retrospective review of 42 patients. European Archives of Oto-Rhino-Laryngology. 266(11). 1767–1773. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hélio Humberto Angotti Carrara Breakdown of academic impact, for papers by J. Daniel Carreon Breakdown of academic impact, for papers by Elisa Gallerani Breakdown of academic impact, for papers by Christian Monnerat Breakdown of academic impact, for papers by Charles Gombé Mbalawa Breakdown of academic impact, for papers by Alexandre A. Jácome Breakdown of academic impact, for papers by Robert Klein Breakdown of academic impact, for papers by Supriya Chopra Breakdown of academic impact, for papers by Timothée Olivier Breakdown of academic impact, for papers by Zhibin Cheng
Rankless by CCL
2026